Hot Products

Immortalized Mouse Dendritic Cells (MutuDC1940)

Cat.No.: CSC-I9098L

Species: Mus musculus

Source: Spleen

Morphology: Small Aggregates

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I9098L
Description
As messengers bridging the innate and adaptive immune system, the conventional tissue-resident DC (cDC) acts as sentinels in secondary lymphoid organs and other tissues for antigen capture and presentation. The Wild-type MutuDC1940 cell line is an immortalized splenic CD8α+subset (CD11chigh,B220-,DEC205+,CD24high,CD11b-) of conventional dendritic cells derived from the CD11c:SV40LgT transgenic mice.The MutuDC1940 cell line retains response to TLR ligands such as CpG (TLR9-L) and PolyIC (TLR3-L) and to a lesser extent LPS (TLR4-L) stimulation by up-regulation of co-stimulatory molecules CD40, CD80 and CD86. In addition to responding to PAMP stimulation and producing Th1 cytokines such as IL-12, these cells are also capable of presenting antigen in the context of both MHC-I and MHC-II, including direct antigen presentation and cross-presentation of cell-associated antigens. Together with TLR3 knockout, TLR9 knockout and Ifnar1 knockout MutuDC, these dendritic cell lines provide a powerful tool in vaccine science and immunotherapy, particularly in strategizing target antigens to CD8α+subset.
Species
Mus musculus
Source
Spleen
Culture Properties
Adherent
Morphology
Small Aggregates
Immortalization Method
Isolated from C57BL/6 transgenic mice carrying SV40 Large T oncogene
Markers
CD11c, CD24, MHC-II+, DEC205, Clec9A, B220, CD11b, IRF4, IRF8, CD4
Application
For Research Use Only
Storage
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20 °C.
Shipping
Dry Ice.
Recommended Products
CIK-HT013 HT® Lenti-hTERT Immortalization Kit
CIK-HT003 HT® Lenti-SV40T Immortalization Kit
Quality Control
1) Direct antigen presentation and cross-antigen presentation were evaluated by the MHC-I (SIINFEKL/OT-I ) and MHC-II (OVA323-339/OT-II) restricted systems;
2) proteome profile and surface markers assessed by RT-PCR; RT-PCR;
3) IL-12 cytokine secretion analyzed using ELISA;
4) Response to PAMP stimulation evaluated by functional assays.
BioSafety Level
II
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

MutuDC1940 is an immortalized mouse dendritic cell line derived from CD8α+ conventional dendritic cell tumors in the spleen of C57BL/6J mice. Cells isolated from CD11c-SV40LgT transgenic mice display spontaneous in vitro immortalization which allows them to proliferate without needing extra growth factors or maturation inducers. The MutuDC1940 cells display similar phenotypic characteristics and functional properties to CD8α+ conventional dendritic cells present in healthy mouse spleens. These cells display surface markers including Clec9A, DEC205, and CD24 and show positive responses to TLR3 and TLR9 activation. The secretion of cytokines and chemokines such as IL-12, IFN-γ, and CCL19 by MutuDC1940 cells shows their mature dendritic cell functionality. They efficiently uptake and process exogenous antigens for presentation to T cells. Studies indicate that in the presence of F-actin and myosin II, MutuDC1940 cells are more effective at cross-presentation. Under IFN-β stimulation, they upregulate the expression of MARCH1 and MARCH8, crucial molecules in antiviral immunity. MutuDC1940 cells can also effectively activate CD8+ and CD4+ T cells, exhibiting strong stimulatory capacity in mixed lymphocyte reactions (MLR).

Morphology of immortalized mouse dendritic cells (MutuDC1940) line cultures.Fig. 1. Morphology of MutuDC1940 line cultures (Marraco SAF, Grosjean F, et al., 2012).

In Vitro Uptake of Nanobody-Functionalized Carriers in Dendritic Cells

Targeting dendritic cells is critical for developing effective tumor nanovaccines. The use of antibodies for targeting requires intricate modifications which consume significant time and money to ensure site-specific attachment. Jung et al. focuses on enhancing the targeting system through nanobody applications rather than using antibodies. The technique employs thiol-maleimide conjugation to attach nanobodies to nanocarriers which results in functionalization time decreasing from days to hours.

To find the optimal nanobody amount per nanocarrier, nanocarriers with increasing nanobody amounts were tested in vitro for uptake by dendritic cells (DCs) (Fig. 2). In MutuDC1940 cells, a type of DC, uptake saturated with higher nanobody amounts (Fig. 2A). At 1000 nanobodies per carrier and above, all cells took up the nanocarriers. Additional experiments used a non-binding reference nanobody and a sample with nanobodies absorbed (not covalently linked) to the carrier (Fig. 2B). Neither control showed significant uptake compared to unmodified nanocarriers. This suggests that targeting is specific to the CD11c receptor and confirms covalent attachment of nanobodies.

Determination of the optimal NB amount via in vitro studies with dendritic cells.Fig. 2. Determination of the optimal NB amount via in vitro studies with DCs (Jung C, Fichter M, et al., 2024).

Ask a Question

Write your own review

For research use only. Not for any other purpose.